《大行報告》瑞銀升農行(01288.HK)評級至「買入」 目標價上調至3.8元
瑞銀發表報告表示,在穩定的淨息差前景、資產負債表持續擴張及資產改善下,預期農業銀行(01288.HK)今年度盈利可回復中單位數的增長,雖然貸款價格或不會像市場先前預期的如此強勁反彈。
該行表示,上調農行評級由「中性」升至「買入」,將目標價由2.6元升至3.8元,此相當預測今年市賬率0.54倍(料今明兩年股本回報率介乎11.4%至11.5%)。
瑞銀指以中期而言,料農行受惠於「十四五」期間的農村振興戰略,並認為其目前估值不高,料隨著中國經濟復甦可能會有進一步的上漲空間。該行將農行2021至2023年度每股盈利預測上調5%至6%,各至0.62、0.66及0.71元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.